Navigation Links
Volcano Corporation Files Counterclaim Asserting St. Jude Infringes Three Volcano Patents; Answers St. Jude's Patent Infringement Claims

SAN DIEGO, Sept. 20 /PRNewswire-FirstCall/ -- Volcano Corporation today said that it believes the patent infringement claims brought against the company by St. Jude Medical Systems AB and its affiliated companies are without merit.  In a filing made today in the United States District Court for the District of Delaware, Volcano denies allegations that its PrimeWire(R) products infringe any valid claim of St. Jude's asserted patents.  Moreover, as described in detail in its answer, Volcano believes that two of the asserted St. Jude patents are unenforceable because they were obtained through acts of fraud on the United States Patent and Trademark Office (USPTO).  Specifically, Volcano believes that the individuals involved in securing these two patents knowingly withheld from the USPTO a patent describing the pioneering work of scientists at Volcano's predecessor company, Cardiometrics, Inc.

In addition, Volcano has alleged that St. Jude's PressureWire (R) products and its RadiAnalyzer(R) Xpress product infringe three Volcano patents.  In its counterclaim, Volcano is seeking injunctive relief and monetary damages.  Volcano intends to demonstrate that St. Jude has adopted Volcano's technology to enable it to compete in the rapidly expanding sensor-equipped guide wire field.

"Volcano believes that it, not St. Jude or Radi Medical, has led the way in Fractional Flow Reserve (FFR) technology by developing the first guide wires to incorporate a solid state pressure sensor, the WaveWire(R).  Volcano's predecessor company was also the first to introduce a guide wire containing a solid state sensor for measuring intravascular flow rates, the FlowWire(R).  Volcano believes that the Cardiometrics patents and Volcano's related innovative products render St. Jude's asserted claims invalid," said Scott Huennekens, chief executive officer of Volcano.

"As the innovator of these guide wire technologies, Volcano intends to set the historical record straight and will vigorously defend against St. Jude's claims. Volcano respects the intellectual property rights of its competitors and expects them do to the same," he added.

About Volcano Corporation

Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information—using sound and light as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company's website at

This news release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this news release regarding the litigation with St. Jude that are not historical facts may be considered "forward-looking statements," including statements relating to the claims and counterclaims alleged in the litigation, and potential impact of such litigation. Forward-looking statements are subject to risks and uncertainties, which may cause Volcano's results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from the results predicted are detailed in the company's annual report on Form 10-K, quarterly reports on Form 10-Q, and other filings made with the Securities and Exchange Commission (SEC), including the current report on Form 8-K filed with the SEC on September 13, 2010. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Volcano undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Corporation Prices $100 Million 2.875 Percent Convertible Senior Notes Due 2015
2. Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015
3. Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast
4. Volcano Will Strongly Defend Against St. Jude Lawsuit
5. Volcano Announces Plans to Introduce Multiple New Products at EuroPCR 2010
6. Physicians Cite Positive First Clinical Experience with Volcanos Eagle Eye® Platinum Digital IVUS Catheter
7. Volcano Corporation Presentation at Bank of America Merrill Lynch Health Care Conference to Be Webcast
8. Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan
9. Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems
10. Volcano Reports 44 Percent Increase in Fourth Quarter Revenues
11. Date Set for LightLab Damages Trial Against Volcano and Axsun
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):